Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: Report from an international workshop

Genes Chromosomes and Cancer

Volumn 33, Issue 4, 2002, Pages 395-400

  Andersen, Mette K ^a   Larson, Richard A ^b   Mauritzson, Nils ^c   Schnittger, Susanne ^d   Jhanwar, Suresh C ^e   Pedersen Bjergaard, Jens ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF CHICAGO   (United States)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GYRASE INHIBITOR; MITOXANTRONE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; BENIGN TUMOR; BREAST CANCER; CANCER CHEMOTHERAPY; CHILD; CHROMOSOME 16; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME INVERSION; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; LATENT PERIOD; LYMPHOMA; MALE; MALIGNANT NEOPLASTIC DISEASE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REMISSION; SOLID TUMOR; SURVIVAL; TRISOMY;

ADOLESCENT; ADULT; AGED; CHILD; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; HUMANS; INVERSION, CHROMOSOME; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; TRANSLOCATION, GENETIC;

EID: 0036197485     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10043     Document Type: Conference Paper

References (14)

1. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements
2. Increased therapy-related leukemia secondary to breast cancer
3. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 Trial
4. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukaemia (AML): Analysis of 1065 patients entered into the United Kingdom Medical Research Council AML 11 trial
5. Data management and statistical methods used in the analysis of balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and therapy-related acute leukemia: Report from an International Workshop
6. Balanced translocations involving chromosome bands 11q23 and 21q22 in therapy-related leukemia
7. Early secondary, acute myeloid leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy
8. Cytogenetic characteristics of therapy-related acute nonlymphocytic leukaemia, preleukaemia and acute myeloproliferative syndrome: Correlation with clinical data for 61 consecutive cases
9. Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukaemia following therapy with cytostatic agents targeting at DNA-topoisomerase II
10. The balanced and the unbalanced chromosome aberrations of acute myeloid leukaemia may develop in different ways and may contribute differently to malignant transformation
11. International Workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: Overview report
12. Incidence and implication of additional chromosome aberrations in acute promyelocytic leukemia with translocation t(15;17)(q2121): A report on 50 patients
13. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukaemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group study